Wuhan Keqian Biology Co.,Ltd (SHA:688526)

China flag China · Delayed Price · Currency is CNY
16.08
+0.23 (1.45%)
Mar 10, 2026, 2:04 PM CST
6.63%
Market Cap 7.35B
Revenue (ttm) 950.29M
Net Income (ttm) 415.60M
Shares Out 463.92M
EPS (ttm) 0.90
PE Ratio 17.61
Forward PE 14.71
Dividend 0.43 (2.68%)
Ex-Dividend Date Jun 16, 2025
Volume 1,379,536
Average Volume 2,330,095
Open 16.00
Previous Close 15.85
Day's Range 15.88 - 16.10
52-Week Range 14.39 - 20.39
Beta 0.54
RSI 47.47
Earnings Date Apr 8, 2026

About SHA:688526

Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. The company offers vaccines for pigs, poultry, and pets, as well as diagnostic reagents. Wuhan Keqian Biology Co.,Ltd was founded in 2001 and is based in Wuhan, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 922
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688526
Full Company Profile

Financial Performance

In 2025, SHA:688526's revenue was 950.29 million, an increase of 0.89% compared to the previous year's 941.92 million. Earnings were 415.60 million, an increase of 8.70%.

Financial Statements

News

There is no news available yet.